Literature DB >> 9472019

4E-BP1, a repressor of mRNA translation, is phosphorylated and inactivated by the Akt(PKB) signaling pathway.

A C Gingras1, S G Kennedy, M A O'Leary, N Sonenberg, N Hay.   

Abstract

Growth factors and hormones activate protein translation by phosphorylation and inactivation of the translational repressors, the eIF4E-binding proteins (4E-BPs), through a wortmannin- and rapamycin-sensitive signaling pathway. The mechanism by which signals emanating from extracellular signals lead to phosphorylation of 4E-BPs is not well understood. Here we demonstrate that the activity of the serine/threonine kinase Akt/PKB is required in a signaling cascade that leads to phosphorylation and inactivation of 4E-BP1. PI 3-kinase elicits the phosphorylation of 4E-BP1 in a wortmannin- and rapamycin-sensitive manner, whereas activated Akt-mediated phosphorylation of 4E-BP1 is wortmannin resistant but rapamycin sensitive. A dominant negative mutant of Akt blocks insulin-mediated phosphorylation of 4E-BP1, indicating that Akt is required for the in vivo phosphorylation of 4E-BP1. Importantly, an activated Akt induces phosphorylation of 4E-BP1 on the same sites that are phosphorylated upon serum stimulation. Similar to what has been observed with serum and growth factors, phosphorylation of 4E-BP1 by Akt inhibits the interaction between 4E-BP1 and eIF-4E. Furthermore, phosphorylation of 4E-BP1 by Akt requires the activity of FRAP/mTOR. FRAP/mTOR may lie downstream of Akt in this signaling cascade. These results demonstrate that the PI 3-kinase-Akt signaling pathway, in concert with FRAP/mTOR, induces the phosphorylation of 4E-BP1.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9472019      PMCID: PMC316523          DOI: 10.1101/gad.12.4.502

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  65 in total

1.  Induction of apoptosis in fibroblasts by c-myc protein.

Authors:  G I Evan; A H Wyllie; C S Gilbert; T D Littlewood; H Land; M Brooks; C M Waters; L Z Penn; D C Hancock
Journal:  Cell       Date:  1992-04-03       Impact factor: 41.582

Review 2.  PI3K: downstream AKTion blocks apoptosis.

Authors:  T F Franke; D R Kaplan; L C Cantley
Journal:  Cell       Date:  1997-02-21       Impact factor: 41.582

3.  Malignant transformation by a eukaryotic initiation factor subunit that binds to mRNA 5' cap.

Authors:  A Lazaris-Karatzas; K S Montine; N Sonenberg
Journal:  Nature       Date:  1990-06-07       Impact factor: 49.962

Review 4.  PKB/Akt: connecting phosphoinositide 3-kinase to cell survival and beyond.

Authors:  B M Marte; J Downward
Journal:  Trends Biochem Sci       Date:  1997-09       Impact factor: 13.807

5.  High-level synthesis in Escherichia coli of functional cap-binding eukaryotic initiation factor eIF-4E and affinity purification using a simplified cap-analog resin.

Authors:  I Edery; M Altmann; N Sonenberg
Journal:  Gene       Date:  1988-12-30       Impact factor: 3.688

6.  Rapamycin-induced inhibition of the 70-kilodalton S6 protein kinase.

Authors:  D J Price; J R Grove; V Calvo; J Avruch; B E Bierer
Journal:  Science       Date:  1992-08-14       Impact factor: 47.728

7.  Rapamycin-FKBP specifically blocks growth-dependent activation of and signaling by the 70 kd S6 protein kinases.

Authors:  J Chung; C J Kuo; G R Crabtree; J Blenis
Journal:  Cell       Date:  1992-06-26       Impact factor: 41.582

8.  Activation of the zeta isozyme of protein kinase C by phosphatidylinositol 3,4,5-trisphosphate.

Authors:  H Nakanishi; K A Brewer; J H Exton
Journal:  J Biol Chem       Date:  1993-01-05       Impact factor: 5.157

9.  A survey of expressed genes in Caenorhabditis elegans.

Authors:  R Waterston; C Martin; M Craxton; C Huynh; A Coulson; L Hillier; R Durbin; P Green; R Shownkeen; N Halloran
Journal:  Nat Genet       Date:  1992-05       Impact factor: 38.330

10.  A second signal supplied by insulin-like growth factor II in oncogene-induced tumorigenesis.

Authors:  G Christofori; P Naik; D Hanahan
Journal:  Nature       Date:  1994-06-02       Impact factor: 49.962

View more
  319 in total

1.  Akt/Protein kinase B inhibits cell death by preventing the release of cytochrome c from mitochondria.

Authors:  S G Kennedy; E S Kandel; T K Cross; N Hay
Journal:  Mol Cell Biol       Date:  1999-08       Impact factor: 4.272

Review 2.  Translational control of viral gene expression in eukaryotes.

Authors:  M Gale; S L Tan; M G Katze
Journal:  Microbiol Mol Biol Rev       Date:  2000-06       Impact factor: 11.056

Review 3.  Forkhead transcription factors are targets of signalling by the proto-oncogene PKB (C-AKT).

Authors:  G J Kops; B M Burgering
Journal:  J Anat       Date:  2000-11       Impact factor: 2.610

4.  Forkhead transcription factors are critical effectors of cell death and cell cycle arrest downstream of PTEN.

Authors:  N Nakamura; S Ramaswamy; F Vazquez; S Signoretti; M Loda; W R Sellers
Journal:  Mol Cell Biol       Date:  2000-12       Impact factor: 4.272

5.  Visualization of biochemical networks in living cells.

Authors:  I Remy; S W Michnick
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-03       Impact factor: 11.205

6.  Hierarchical phosphorylation of the translation inhibitor 4E-BP1.

Authors:  A C Gingras; B Raught; S P Gygi; A Niedzwiecka; M Miron; S K Burley; R D Polakiewicz; A Wyslouch-Cieszynska; R Aebersold; N Sonenberg
Journal:  Genes Dev       Date:  2001-11-01       Impact factor: 11.361

7.  Serotonin activates S6 kinase in a rapamycin-sensitive manner in Aplysia synaptosomes.

Authors:  A Khan; A M Pepio; W S Sossin
Journal:  J Neurosci       Date:  2001-01-15       Impact factor: 6.167

Review 8.  Protein synthesis in the dendrite.

Authors:  Shao Jun Tang; Erin M Schuman
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2002-04-29       Impact factor: 6.237

9.  Regulation of mTORC1 by the Rab and Arf GTPases.

Authors:  Li Li; Eunjung Kim; Haixin Yuan; Ken Inoki; Pankuri Goraksha-Hicks; Rachel L Schiesher; Thomas P Neufeld; Kun-Liang Guan
Journal:  J Biol Chem       Date:  2010-05-10       Impact factor: 5.157

Review 10.  Utility of mTOR inhibition in hematologic malignancies.

Authors:  Anas Younes; Nousheen Samad
Journal:  Oncologist       Date:  2011-05-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.